Clinical Results of Fibroid Embolisation, Trials and Registries

  • Reddi Prasad Yadavali
  • Jon. G. Moss
Part of the Medical Radiology book series (MEDRAD)


Uterine fibroids are the most common tumour to affect women. Many are asymptomatic but when treatment is required there is almost always a choice. Uterine artery embolisation (UAE) is a relatively new minimally invasive technique and is usually one of the options. Initially slow to be accepted it is now a recognised, approved and funded procedure in most countries. It is the duty of any doctor to discuss all treatment options available with the patient. This discussion should be based on the best evidence available and it is the duty of the doctor to remain up-to-date with that information. The discussion should be fair, balanced and non-prejudicial. After the consultation patients should feel empowered to make an informed choice. The choice is usually between surgery and UAE and this chapter attempts to inform the reader of the current evidence base.


Uterine Artery Embolisation Uterine Sarcoma Endometrial Ablation Menstrual Blood Loss Hysterectomy Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Evidence-Based Medicine


Health-Related Quality of Life


Short Form (36) Health Survey


Uterine Artery Embolisation


Uterine Fibroid Symptom and Quality of Life


United Kingdom


United States of America


  1. Beinfeld MT, Bosch JL, Isaacson KB, Gazelle GS (2004) Cost-effectiveness of uterine artery embolization and hysterectomy for uterine fibroids. Radiology 230:207–213PubMedCrossRefGoogle Scholar
  2. British Society of Interventional Radiology (BSIR) UK fibroid registry report;
  3. de Blok S, de Vries C, Prinssen HM, Blaauwgeers HL, Jorna- Meijer LB (2003) Fatal sepsis after uterine artery embolization with microspheres. J Vasc Interv Radiol 14:779–783PubMedCrossRefGoogle Scholar
  4. Edwards R, Moss J, Lumsden M et al (2007) Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 356:360–370PubMedCrossRefGoogle Scholar
  5. Goodwin SC, Spies JB, Worthinton-Kirsch R et al (2008) Uterine artery embolization for treatment of leiomyomata, long-term outcomes from the FIBROID registry. Obstet Gynecol 111:22–33PubMedCrossRefGoogle Scholar
  6. Gupta JK, Sinha AS, Lumsden MA et al (2006) Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 1:CD005073Google Scholar
  7. Hamoda H, Tait P, Edmonds D (2009) Fatal pulmonary embolism after uterine artery fibroid embolisation. Cardiovasc Interv Radiol 32:1080–1082CrossRefGoogle Scholar
  8. Hehenkamp WJ, Volkers NA, Donderwinkel PF et al (2005) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and post-procedural results from a randomized controlled trial. Am J Obstet Gynecol 193:1618–1629PubMedCrossRefGoogle Scholar
  9. Hehenkamp WJ, Volkers NA, Broekmans FJ et al (2007) Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod 22:1996–2005PubMedCrossRefGoogle Scholar
  10. Hehenkamp WJ, Volkers NA, Birnie E, Reekers JA, Ankum WM (2008) Symptomatic uterine fibroids: treatment with uterine artery embolization or hysterectomy: results from the randomized clinical embolisation versus hysterectomy (EMMY) trial. Radiology 246:823–832PubMedCrossRefGoogle Scholar
  11. Hirst A, Dutton S, Wu O, Briggs A, Edwards C,Waldenmaier L et al (2008) A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study. Health Technol Assess 12(5):1–248PubMedGoogle Scholar
  12. Homer H, Saridogan E (2010) Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril 94:324–330PubMedCrossRefGoogle Scholar
  13. Lanocita R, Frigerio L, Patelli G, Di Tolla G, Spreafico C (1999) A fatal complication of percutaneous transcatheter embolization for treatment of uterine fibroids. Second International Symposium on the Embolization of Uterine Myomata, BostonGoogle Scholar
  14. Landow W. (2001) Deaths after uterine embolization. In: Spies J, Warren E, Mathias S, Walsh S, Roth A, Pentecost M. Uterine Fibroid Embolization. PersonalGoogle Scholar
  15. Lefebvre G, Vilos G, Asch M (2004) Society of obstetricians and gynaecologists of Canada, Canadian Association of Radiologists, Canadian Interventional Radiology Association, uterine fibroid embolization (UFE). J Obstet Gynaecol Can 26(899–911):913–928Google Scholar
  16. Manyonda IT, Bratby M, Horst JS (2011) Uterine artery embolization versus myomectomy: impact on quality of life—results of the FUME (fibroids of the uterus: myomectomy versus embolization) trial. Cardiovasc Intervent Radiol. doi  10.1007/s00270-011-0228-5
  17. Mara M, Fucikova Z, Maskova J, Kuzel D, Haakova L (2006) Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 126:226–233PubMedCrossRefGoogle Scholar
  18. Mara M, Maskova J, Fucikova Z et al (2008) Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 31:73–85PubMedCentralPubMedCrossRefGoogle Scholar
  19. Moss J, Cooper K, Khaund A, Murray L, Murray G, Wu O, Craig L, Lumsden M (2011) Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG 118:936–944PubMedCrossRefGoogle Scholar
  20. Pinto I, Chimeno P, Paul L et al (2003) Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment—a prospective randomized, and controlled clinical trial. Radiology 226:425–431PubMedCrossRefGoogle Scholar
  21. Pourrat XJ, Fourquet F, Guerif F, Viratelle N, Herbreteau D, Marret H (2003) Medico-economic approach to the management of uterine myomas: a 6-month cost-effectiveness study of pelvic embolization versus vaginal hysterectomy. Eur J Obstet Gynecol Reprod Biol 111:59–64PubMedCrossRefGoogle Scholar
  22. Rashid S, Khaund A, Murray L, Moss J, Cooper K, Lyons D, Murray G, Lumsden M (2010) The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. BJOG 117:985–989PubMedCrossRefGoogle Scholar
  23. Ravina JH, Herbreteau D, Ciraru-Vigneron N, Houdart E, Aymar A, Merland JJ (1995) Arterial embolization to treat uterine myomata. Lancet 346:671–672PubMedCrossRefGoogle Scholar
  24. Sacks D, McClenny T, Cardella J, Lewis C (2003) Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–S202PubMedCrossRefGoogle Scholar
  25. Scottish Intercollegiate Guidelines Network.
  26. Spies JB, Coyne K, Guaou GN, Boyle D, Skyrnarz-Murphy K, Gonzalves SM et al (2002) The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 99(2):290–300PubMedCrossRefGoogle Scholar
  27. Spies JB, Myers ER, Worthinton-Kirsch R et al (2005) The FIBROID registry, symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 106:1309–1318PubMedCrossRefGoogle Scholar
  28. Tropeano G, Statsi CD, Amoroso S et al (2010) Long-term effects of uterine fibroid embolization on ovarian reserve: a prospective cohort study. Fertil Steril 94:2296–2300PubMedCrossRefGoogle Scholar
  29. Van der Kooij SM, Hehenkamp WJ, Volkers NA et al (2010) Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am J Obstet Gynecol 203:105.e1–13Google Scholar
  30. Van der Kooij SM, Bipat S, Hehenkamp WJK et al (2011) Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. Am J Obstet Gynecol 205:317.e1–18Google Scholar
  31. Vashisht A, Studd J, Carey A, Burn P (1999) Fatal septicaemia after fibroid embolisation. Lancet 354(9175):307–308PubMedCrossRefGoogle Scholar
  32. Volkers NA, Hehenkamp WJ, Birnie E et al (2006) Uterine artery embolization in the treatment of symptomatic uterine fibroids (EMMY trial): periprocedural results and complications. J Vasc Interv Radiol 17:471–480PubMedCrossRefGoogle Scholar
  33. Volkers NA, Hehenkamp WJ, Birnie E, Ankum WM, Reekers JA (2007) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol 196(519):e1–e11PubMedGoogle Scholar
  34. Volkers NA, Hehenkamp WJ, Smit P et al (2008) Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. J Vasc Interv Radiol 19:1007–1017PubMedCrossRefGoogle Scholar
  35. Worthinton-Kirsch R, Spies J, Myers E et al (2005) The fibroid registry for outcomes data (FIBROID) for uterine embolization short-term outcomes. Obstet Gynecol 106:52–59CrossRefGoogle Scholar
  36. Wu O, Briggs A, Dutton S, Hirst A, Maresh M, Nicholson A et al (2007) Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study. BJOG 114:1352–1362PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Department of Radiology Aberdeen Royal InfirmaryConsultant Interventional RadiologistAberdeenUK
  2. 2.Department of Radiology Gartnavel General HospitalConsultant Interventional RadiologistGlasgowUK

Personalised recommendations